{"company":{"id":2472022,"name":"Humacyte","domain":"humacyte.com","url":"https://alion.io/company/humacyte"},"section":"news","answer":"Humacyte: 10 headlines on record, 5 headlines in the last 90 days. Its story counts 4 milestones.","figures":[{"label":"Headlines","value":"10"},{"label":"In 90 days","value":"5"},{"label":"Milestones","value":"4"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":10},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":4}],"news":[{"date":"2026-10-09","kind":"News","title":"Humacyte (HUMA) Stock Fair Value Moves Lower After Analyst Target Cuts","source":"YahooFinance","url":"https://finance.yahoo.com/markets/stocks/articles/humacyte-huma-stock-fair-value-051619573.html"},{"date":"2026-10-07","kind":"Award","title":"Humacyte Director D. Scott Coward Awarded 125,000 Stock Options with Four-Year Vesting","source":"kalkineus","url":"https://kalkinemedia.com/us/news/announcements/humacyte-director-d-scott-coward-awarded-125000-stock-options-with-four-year-vesting"},{"date":"2026-10-07","kind":"News","title":"Humacyte Director Paul Brian Kuznik Receives 125,000 Stock Options with $0.478 Exercise Price","source":"kalkineus","url":"https://kalkinemedia.com/us/news/announcements/humacyte-director-paul-brian-kuznik-receives-125000-stock-options-with-0478-exercise-price"},{"date":"2026-10-07","kind":"News","title":"Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade","source":"YahooFinance","url":"https://finance.yahoo.com/markets/stocks/articles/humacyte-inc-huma-stock-slides-210002704.html"},{"date":"2026-09-28","kind":"News","title":"Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik","source":"marketscreener.com","url":"https://marketscreener.com/news/humacyte-expands-board-expertise-with-appointment-of-scott-coward-and-paul-kuznik-ce785adcdc8ef223"},{"date":"2025-10-14","kind":"Press release","title":"D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering","source":"newswire.com","url":"https://newswire.com/news/d-boral-capital-acted-as-exclusive-placement-agent-to-humacyte-nasdaq-huma-in"},{"date":"2025-03-24","kind":"News","title":"Humacyte: Symvess' Approval And Launch Are Just The First Steps To Adoption (Downgrade)","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4769946-humacyte-symvess-approval-and-launch-are-just-first-steps"},{"date":"2025-02-25","kind":"News","title":"Humacyte Launches Symvess For Extremity Vascular Trauma","source":"nasdaq.com","url":"https://nasdaq.com/articles/humacyte-launches-symvess-extremity-vascular-trauma"},{"date":"2024-11-05","kind":"News","title":"Humacyte (HUMA) Faces Key Regulatory Hurdles Ahead of Q3 Earnings","source":"nasdaq.com","url":"https://nasdaq.com/articles/humacyte-huma-faces-key-regulatory-hurdles-ahead-q3-earnings"},{"date":"2024-07-22","kind":"News","title":"Humacyte: Creating New Medical Frontiers With Bioengineered Human Tissue","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4705581-humacyte-creating-new-medical-frontiers-with-bioengineered-human-tissue"}],"story":[{"title":"Went public NASDAQ: HUMA"},{"title":"Launched Humacyte Launches Symvess For Extremity Vascular Trauma · nasdaq.com","url":"https://nasdaq.com/articles/humacyte-launches-symvess-extremity-vascular-trauma"},{"title":"Raised a round Venture round $150M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1385943/000138594318000004/"},{"title":"Raised a round Venture round $75M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1385943/000138594318000003/"}],"as_of":"2026-11-18","cite":"Humacyte, News. Alion, Nov 18, 2026. https://alion.io/company/humacyte/news","html_url":"https://alion.io/company/humacyte/news","json_url":"https://alion.io/company/humacyte/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-18T04:01:42Z"}}